COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 157 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $184,000 | -9.4% | 11,480 | 0.0% | 0.01% | -22.2% |
Q2 2022 | $203,000 | -13.2% | 11,480 | 0.0% | 0.02% | 0.0% |
Q1 2022 | $234,000 | +9.3% | 11,480 | 0.0% | 0.02% | +12.5% |
Q4 2021 | $214,000 | -5.7% | 11,480 | 0.0% | 0.02% | -11.1% |
Q3 2021 | $227,000 | -11.0% | 11,480 | +6.4% | 0.02% | +12.5% |
Q2 2021 | $255,000 | 0.0% | 10,793 | +0.1% | 0.02% | -11.1% |
Q1 2021 | $255,000 | +18.1% | 10,780 | 0.0% | 0.02% | 0.0% |
Q4 2020 | $216,000 | -3.6% | 10,780 | 0.0% | 0.02% | -18.2% |
Q3 2020 | $224,000 | +14.9% | 10,780 | -3.1% | 0.02% | -18.5% |
Q2 2020 | $195,000 | +4.3% | 11,130 | -2.7% | 0.03% | 0.0% |
Q1 2020 | $187,000 | -19.7% | 11,442 | +1.0% | 0.03% | -3.6% |
Q4 2019 | $233,000 | +57.4% | 11,330 | -12.4% | 0.03% | +40.0% |
Q3 2019 | $148,000 | -12.9% | 12,930 | 0.0% | 0.02% | -20.0% |
Q2 2019 | $170,000 | -11.9% | 12,930 | +1.4% | 0.02% | -21.9% |
Q1 2019 | $193,000 | -11.9% | 12,750 | 0.0% | 0.03% | -23.8% |
Q4 2018 | $219,000 | – | 12,750 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |